le vendredi 27 juillet 2018, à 08:44. Posté
par Juan
What do you like doing in your spare time? http://www.coolcatsites.com/stmap_66aa0.html?viagra.piroxicam.clofazimine pocket package strategy Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.